These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 6705009)
1. Pharmacokinetics in the 1980s. Balant LP Clin Ther; 1984; 6(2):112-24. PubMed ID: 6705009 [TBL] [Abstract][Full Text] [Related]
2. Consequences of renal insufficiency on the hepatic clearance of some drugs. Balant LP; Dayer P; Fabre J Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317 [TBL] [Abstract][Full Text] [Related]
3. Primer on clinical pharmacokinetics. Bauer LA Am J Hosp Pharm; 1983 Oct; 40(10):1637-41. PubMed ID: 6638025 [TBL] [Abstract][Full Text] [Related]
4. [The use of the concepts of "half-life" and "clearance" in practice and in pharmacokinetics]. Raaflaub J Schweiz Med Wochenschr; 1981 Sep; 111(38):1406-11. PubMed ID: 7280641 [TBL] [Abstract][Full Text] [Related]
5. Using pharmacokinetics in drug therapy. VII: Pharmacokinetic factors influencing drug therapy in the aged. Schumacher GE Am J Hosp Pharm; 1980 Apr; 37(4):559-62. PubMed ID: 6990755 [TBL] [Abstract][Full Text] [Related]
6. The influence of some disease states on drug disposition. Wilson K; Bromberg T Methods Find Exp Clin Pharmacol; 1981; 3(3):189-200. PubMed ID: 7253775 [TBL] [Abstract][Full Text] [Related]
8. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations]. Pellegrin P; Lesne M J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic changes in critical illness. Boucher BA; Wood GC; Swanson JM Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999 [TBL] [Abstract][Full Text] [Related]
10. Disease-induced modifications of drug pharmacokinetics. Barre J; Houin G; Brunner F; Bree F; Tillement JP Int J Clin Pharmacol Res; 1983; 3(4):215-26. PubMed ID: 6381335 [TBL] [Abstract][Full Text] [Related]
11. The genetic control of drug oxidation in the liver. Dayer P; Balant L; Fabre J Int J Clin Pharmacol Res; 1983; 3(6):421-5. PubMed ID: 6147316 [TBL] [Abstract][Full Text] [Related]
12. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E; Cloyd J; Critchley D; Fuseau E Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564 [TBL] [Abstract][Full Text] [Related]
14. Variability in human drug metabolism and its implications. Breimer DD Int J Clin Pharmacol Res; 1983; 3(6):399-413. PubMed ID: 6381339 [TBL] [Abstract][Full Text] [Related]
15. [Stability and/or variability of the expression of genetic polymorphism of hydroxylation and acetylation in patients with various pathologies and under various treatments]. Bechtel P; Joanne C; Bechtel Y; Grandmottet M; Jounet JM Ann Biol Clin (Paris); 1986; 44(4):361-7. PubMed ID: 3538951 [TBL] [Abstract][Full Text] [Related]
16. [The prediction of enantiomeric differences in the pharmacokinetic parameters of drugs by using a physiological perfusion model]. PiotrovskiÄ VK; Shvachko EV; Trnovec T Eksp Klin Farmakol; 1994; 57(5):37-40. PubMed ID: 7696904 [TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
18. Clearance by the liver: current concepts in understanding the hepatic disposition of drugs. Larrey D; Branch RA Semin Liver Dis; 1983 Nov; 3(4):285-97. PubMed ID: 6359424 [No Abstract] [Full Text] [Related]
20. [Dosage of drugs with regard to their distribution volume and biological half-life]. Dahl SG Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1201-2. PubMed ID: 4839999 [No Abstract] [Full Text] [Related] [Next] [New Search]